Michael Cross
- Hematology top 1%
- Acute Myeloid Leukemia Research 30
- Hematopoietic Stem Cell Transplantation 26
- Chronic Myeloid Leukemia Treatments 14
- Genetics top 2%
- Mesenchymal stem cell research 12
- Chronic Lymphocytic Leukemia Research 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Cancer Research top 5%
- Molecular Medicine top 5%
- Endocrinology top 5%
-
- Pluripotent Stem Cells Research 8
- Epigenetics and DNA Methylation 8
- Co-authors
- T. M. DexterRainer RenkawitzVassilis KoronakisColin HughesDietger NiederwieserAngela WedelTariq EnverInge Mangelsdorf
- Cited by
- HematologyGeneticsCancer Research
- Journals
- Blood (25 papers)British Journal of Haematology (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Michael Cross
132 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Hematology 910
- Genetics 552
- Cancer Research 568
- Molecular Medicine 169
- Endocrinology 165
Countries citing papers authored by Michael Cross
This map shows the geographic impact of Michael Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cross more than expected).
Fields of papers citing papers by Michael Cross
This network shows the impact of papers produced by Michael Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cross. The network helps show where Michael Cross may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Cross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 16 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 6 | |
| 6 | 2019 | 39 | |
| 7 | 2017 | 0 | |
| 8 | 2017 | 1 | |
| 9 | 2017 | 1 | |
| 10 | 2008 | 13 | |
| 11 | 2008 | 8 | |
| 12 | 1999 | 4 | |
| 13 | 1998 | 5 | |
| 14 | Provider automation. Using the Internet to access records. | 1997 | 1 |
| 15 | 1997 | 113 | |
| 16 | 1997 | 19 | |
| 17 | Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation. | 1995 | 21 |
| 18 | 1995 | 42 | |
| 19 | 1991 | 117 | |
| 20 | 1990 | 72 |
About Michael Cross
Michael Cross is a scholar working on Hematology, Genetics and Cancer Research, having authored 136 papers that have together received 3.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (30 papers), Hematopoietic Stem Cell Transplantation (26 papers), Chronic Myeloid Leukemia Treatments (14 papers), Mesenchymal stem cell research (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Pluripotent Stem Cells Research (8 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Hematology (910 citations), Genetics (552 citations) and Cancer Research (568 citations). Michael Cross has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include T. M. Dexter, Rainer Renkawitz, Vassilis Koronakis, Colin Hughes, Dietger Niederwieser, Angela Wedel, Tariq Enver, Inge Mangelsdorf, Christopher M. Thomas and Eva Koronakis. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Leukemia and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.